These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1275551)

  • 21. Porphyria cutanea tarda and pregnancy.
    Goerz G; Hammer G
    Dermatologica; 1983 Jun; 166(6):316-8. PubMed ID: 6884554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of chloroquine therapy in seven cases of porphyria cutanea tarda: influence on clinical and chemical-clinical pictures (author's transl)].
    Arbosti G; Nava C; Ghezzi I; Grisler R; Brambilla G
    Med Lav; 1979; 70(3):239-47. PubMed ID: 470825
    [No Abstract]   [Full Text] [Related]  

  • 23. Incorporation of (4-14 C) -aminolaevulinate into urinary porphyrins in porphyria cutanea tarda: effect of chloroquine therapy.
    Taljaard JJ; Shanley BC; Joubert SM; Deppe WM
    Clin Sci; 1973 Jun; 44(6):571-81. PubMed ID: 4713665
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda.
    Felsher BF; Redeker AG
    Medicine (Baltimore); 1966 Nov; 45(6):575-83. PubMed ID: 5925910
    [No Abstract]   [Full Text] [Related]  

  • 25. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.
    Marsden JT; Rees DC
    J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical differentiation of the porphyrias.
    Hindmarsh JT; Oliveras L; Greenway DC
    Clin Biochem; 1999 Nov; 32(8):609-19. PubMed ID: 10638943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of porphyrin-excretion in female estrogen-induced porphyria cutanea tarda.
    Enríquez de Salamanca R; Mingo D; Chinarro S; Muñoz JJ; Perpiñá J
    Arch Dermatol Res; 1982; 274(1-2):179-84. PubMed ID: 7165364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Porphyria erythropoietica congenita Günther and chloroquine (author's transl)].
    Ippen H; Tillmann W; Seubert S; Seubert A
    Klin Wochenschr; 1978 Jun; 56(12):623-4. PubMed ID: 682527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular basis of the action of chloroquine in porphyria cutanea tarda.
    Scholnick PL; Epstein J; Marver HS
    J Invest Dermatol; 1973 Oct; 61(4):226-32. PubMed ID: 4744026
    [No Abstract]   [Full Text] [Related]  

  • 31. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine in the treatment of porphyria cutanea tarda.
    Tsega E; Besrat A; Damtew B; Seyoum E; Landells JW
    Trans R Soc Trop Med Hyg; 1981; 75(3):401-4. PubMed ID: 7324107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urinary porphyrin excretion in human immunodeficiency virus infection].
    Mouly F; Janier M; Nordmann Y; Flageul B
    Presse Med; 1996 Oct; 25(32):1541-5. PubMed ID: 8952661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
    Doss MO
    Z Hautkr; 1988 Apr; 63(4):282-9. PubMed ID: 3291437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Does paraneoplastic porphyria cutanea tarda exist?].
    Köstler E
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):35-40. PubMed ID: 3371236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Porphyria and porphyrinuria].
    Schoenfeld N; Mamet R; Mevasser R; Atsmon A
    Harefuah; 1993 Dec; 125(12):449-52, 496. PubMed ID: 8112676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I; Nagy E
    Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda.
    Stölzel U; Köstler E; Schuppan D; Richter M; Wollina U; Doss MO; Wittekind C; Tannapfel A
    Arch Dermatol; 2003 Mar; 139(3):309-13. PubMed ID: 12622622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Porphyrias-what is verified?].
    Stölzel U; Kubisch I; Stauch T
    Internist (Berl); 2018 Dec; 59(12):1239-1248. PubMed ID: 30328490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nephrologists and porphyrias].
    Canavese C; Gabrielli D; Guida C; Cappellini MD
    G Ital Nefrol; 2002; 19(4):393-412. PubMed ID: 12369042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.